The global needle-free vaccine injector market is projected to grow significantly, with estimated sales valued at USD 1,844.6 million in 2024 and anticipated to reach USD 3,091.6 million by 2034. This growth translates to a CAGR of 6.5% during the forecast period. In 2023, the revenue generated by needle-free vaccine injectors was approximately USD 1.73 billion, highlighting a strong demand for innovative vaccination solutions.
Key factors contributing to the growth of the needle-free vaccine injector market include:
- Increasing Vaccination Awareness: The global push for vaccination, particularly in response to recent health crises, has heightened interest in painless and efficient vaccination methods.
- Enhanced Patient Comfort and Compliance: Needle-free injectors offer a less invasive alternative, which can alleviate fear and discomfort associated with traditional needles, thereby improving patient compliance, especially among children and needle-phobic individuals.
- Technological Advancements: Innovations in injector technology, such as high-pressure delivery systems and smart injectors, are enhancing the efficacy and reliability of needle-free vaccinations.
- Growing Demand in Mass Immunization Campaigns: Needle-free injectors are particularly beneficial for large-scale vaccination campaigns, allowing for quicker and more efficient delivery of vaccines in diverse settings.
- Supportive Government Initiatives: Many governments and health organizations are investing in needle-free technology to improve immunization rates and public health outcomes, further driving market growth.
Technology innovations such as microneedle systems and high-pressure jet injectors are further giving a boost to the market for needle-free vaccine injectors. Innovations such as these improve the efficiency and precision of needle-free injectors, just like the use of needle-free vaccines for chronic diseases.
The need for convenient vaccination options, along with the expansion of vaccination programs and global vaccination initiatives, supports the optimistic outlook for the needle-free vaccine injectors market.
As technological advancements continue to progress across areas related to comfort, safety, and effectiveness, different configurations of these needle-free vaccine injectors will provide less invasive, cheap, and convenient solutions for vaccination. This trend will contribute to both the reasonable confidence and anticipated growth of the market as it develops further over the next few years.
The increasing incidence rates of vaccine-preventable diseases and greater emphasis on immunization programs are likely to raise the demand for injectors of needle-free vaccines. A key advantages are less risk of needle-stick injuries and improved efficiency in the administration of vaccines.
With rising concerns about health threats experienced around the globe such as the continued impact of COVID-19 and disease from other infections. The use of needle-free injectors allows for greater convenience and safety that responds to the global priority to increase vaccination numbers globally and to respond to future disease epidemics or pandemics.
Government initiatives are also extremely important and provide support for these trends. Many governments and health organizations are increasing the focus on expanding vaccination coverage and promoting the use of new or modified needle-free injectors as part of that plan.
Governments want increased access to vaccines, reduced waste of vaccines, and improved outcomes for public health. Many countries have added needle-free injectors to their national immunization programs to facilitate vaccine delivery and safety during increased immunization access and vaccination rates.
Competitive Landscape
The competition and evolution of the landscape of the needle-free vaccine injectors market are continuous, as companies fight amongst each other on different innovative steps and technological improvements given the needs of the different segments. Growing demand for advanced patient-friendly vaccination solutions in the marketplace propels growth in this sector and has prompted key competition and strategic moves among key stakeholders in the industry.
Recent Industry Developments in Needle-Free Vaccine Injectors Market
- On June 12, 2024, Antares Pharma, Inc. unveiled the Vibex® Tjet Needle-Free Injector, a state-of-the-art device designed to enhance vaccine delivery precision and patient comfort. This new injector is aimed at broadening the range of vaccines that can be administered effectively without needles, catering to both routine and emergency vaccination needs.
- In May 2024, INJEX Pharma AG launched its latest needle-free injector, the INJEX 30, which features advanced microneedle technology to improve the accuracy of drug delivery. This innovative injector is expected to address the growing demand for more efficient and less invasive vaccination methods, particularly in pediatric and geriatric populations.
- On July 22, 2024, Endo International plc entered into a strategic partnership with PharmaJet to co-develop a next-generation jet-based needle-free injector. This collaboration aims to leverage both companies’ expertise in injector technology to enhance vaccine administration efficiency and expand the device’s application to include emerging vaccines for new pathogens.
A Detailed Full Report
Key Players of Needle-Free Vaccine Injectors Industry
- Antares Pharma, Inc. (USA)
- INJEX Pharma AG (Germany)
- Endo International plc (USA)
- PharmaJet (USA)
- European Pharma Group (Netherland)
- Bioject Medical Technologies Inc. (USA)
- Medical International Technology, Inc. (USA)
- Valeritas, Inc. (USA)
- National Medical Products Inc. (USA)
- PenJet Corporation (USA)
- Crossject SA (France)
Key Segments of Needle-Free Vaccine Injectors Industry
By Product:
In terms of Product, the industry is divided into prefilled needle-free injectors and fillable needle-free injectors
By Technology:
In terms of technology, the industry is divided into jet-based needle-free injection, vibration-based needle-free injectors, laser-powered needle-free injectors and spring-based needle-free injectors
By Usability:
In terms of usability, the industry is segregated into disposable needle-free injectors and reusable needle-free injectors
By Medication:
In terms of medication, the industry is segregated into liquid-based needle free injectors, projectile/depot-based needle free injectors and powder-based needle free injectors
By Site of Delivery:
In terms of site of delivery, the industry is segregated into intra dermal injectors, subcutaneous injectors and intramuscular injectors
By Region:
Key countries of North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
